Methylboronic Acid → [4-(1,1-Dioxo-1lambda6-isothiazolidin-2-yl)-2-methanesulfonylphenyl][4-(4-methylbenzoyl)piperidin-1-yl]methanone
Reaction equation
Cl[C:2]1[CH:34]=[CH:33][C:5]([C:6]([CH:8]2[CH2:13][CH2:12][N:11]([C:14]([C:16]3[CH:21]=[CH:20][C:19]([N:22]4[CH2:26][CH2:25][CH2:24][S:23]4(=[O:28])=[O:27])=[CH:18][C:17]=3[S:29]([CH3:32])(=[O:31])=[O:30])=[O:15])[CH2:10][CH2:9]2)=[O:7])=[CH:4][CH:3]=1.[CH3:35]B(O)O>>[O:27]=[S:23]1(=[O:28])[CH2:24][CH2:25][CH2:26][N:22]1[C:19]1[CH:20]=[CH:21][C:16]([C:14]([N:11]2[CH2:12][CH2:13][CH:8]([C:6](=[O:7])[C:5]3[CH:33]=[CH:34][C:2]([CH3:35])=[CH:3][CH:4]=3)[CH2:9][CH2:10]2)=[O:15])=[C:17]([S:29]([CH3:32])(=[O:31])=[O:30])[CH:18]=1Participants
3
Reactant 2
Product 1
Procedure
Using 4-(1,1-dioxo-1λ6-isothiazolidin-2-yl)-2-methanesulfonylbenzoic acid (138 mg) described in Preparation Example 22 and 4-(4-chlorobenzoyl)piperidine (97 mg) and by the reaction and treatment in the same manner as in Example 87, [4-(4-chlorobenzoyl)piperidin-1-yl][4-(1,1-dioxo-1λ6-isothiazolidin-2-yl)-2-methanesulfonylphenyl]methanone (76 mg) was obtained. Using the obtained [4-(4-chlorobenzoyl)piperidin-1-yl][4-(1,1-dioxo-1λ6-isothiazolidin-2-yl)-2-methanesulfonylphenyl]methanone (76 mg) and methylboronic acid (37 mg) and by the reaction and treatment in the same manner as in Example 115, the title compound (37 mg) was obtained.
Workup
- customby the reaction and treatment in the same manner as in Example 115
Sources & evidence
- ORD record
- ord-31c50ae43f4f4906af6e680bbf282952
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…